Pages that link to "Q36830255"

The following pages link to Mitochondrial involvement in schizophrenia and other functional psychoses (Q36830255):

Displaying 41 items.

• Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome (Q28587450) (← links)
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence (Q29618819) (← links)
• Leukocyte mitochondrial DNA copy number in blood is not associated with major depressive disorder in young adults (Q33584175) (← links)
• Assessment of cytochrome C oxidase dysfunction in the substantia nigra/ventral tegmental area in schizophrenia (Q33773639) (← links)
• The other, forgotten genome: mitochondrial DNA and mental disorders (Q34416941) (← links)
• A Review and Update on Tourette Syndrome: Where Is the Field Headed? (Q34516696) (← links)
• The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia (Q34612231) (← links)
• New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations (Q34729740) (← links)
• Mitochondrial processing peptidases (Q34793194) (← links)
• Glucose/mitochondria in neurological conditions (Q34991055) (← links)
• Schizophrenia: from phenomenology to neurobiology (Q35146132) (← links)
• Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia (Q35173614) (← links)
• Comparative Pharmacology of Risperidone and Paliperidone (Q35807345) (← links)
• Whether ionizing radiation is a risk factor for schizophrenia spectrum disorders? (Q36307082) (← links)
• Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia (Q36923043) (← links)
• Systematic association studies of mitochondrial DNA variations in schizophrenia: focus on the ND5 gene (Q37076359) (← links)
• Target identification for CNS diseases by transcriptional profiling. (Q37175279) (← links)
• Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders (Q37778476) (← links)
• New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. (Q37978196) (← links)
• The mitochondrial genome and psychiatric illness (Q38034189) (← links)
• Perturbation in Mitochondrial Network Dynamics and in Complex I Dependent Cellular Respiration in Schizophrenia (Q39577276) (← links)
• Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome (Q41833688) (← links)
• Interstitial 7q31.1 copy number variations disrupting IMMP2L gene are associated with a wide spectrum of neurodevelopmental disorders. (Q41887995) (← links)
• Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients (Q42448361) (← links)
• Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia (Q42501952) (← links)
• Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. (Q43940200) (← links)
• State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia (Q44194149) (← links)
• Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene (Q44334386) (← links)
• Schizophrenia: maternal inheritance and heteroplasmy of mtDNA mutations (Q44419979) (← links)
• 99mTc-HMPAO distribution at SPECT is associated with succinate-cytochrome c reductase (SCR) activity in subjects with psychiatric disorders (Q44794934) (← links)
• Mitochondrial enzymes in schizophrenia (Q45085060) (← links)
• In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. (Q46010049) (← links)
• Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats (Q48264510) (← links)
• Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder (Q48324144) (← links)
• Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex (Q48524844) (← links)
• Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium (Q48583796) (← links)
• Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia (Q50306114) (← links)
• Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease (Q64868646) (← links)
• Calcium signaling dysfunction in schizophrenia: a unifying approach (Q79073580) (← links)
• The genetics of Tourette syndrome (Q83629652) (← links)
• Mitochondrial deficits in human iPSC-derived neurons from patients with 22q11.2 deletion syndrome and schizophrenia (Q91329654) (← links)